Professor Nicole Soranzo and Dr David Adams elected to the Academy of Medical Sciences

Sanger researchers focusing on human genetics and cancer are recognised with prestigious Fellowships

Professor Nicole Soranzo and Dr David Adams elected to the Academy of Medical Sciences

Wellcome Sanger Institute Group Leaders Professor Nicole Soranzo and Dr David Adams are two of 48 world-leading scientists being honoured by the Academy of Medical Sciences for their outstanding contribution to biomedical science. David and Nicole were chosen from 410 candidates to join more than 1,200 existing Fellows whose innovative research is advancing understanding of health and disease and is benefitting society.

“Later this year the Academy will celebrate 20 years of supporting the translation of biomedical and health research into benefits for society. As we celebrate this special anniversary we stand at a crossroads of both enormous health challenges and great opportunity for medical sciences. So I am delighted to see the remarkable breadth and depth of the expertise within our 48 new Fellows. We look forward to these experts joining us in addressing the health challenges we face head on and exploiting opportunities to improve health in the UK and internationally.”

Professor Sir Robert Lechler PMedSci, President of the Academy of Medical Sciences

Professor Nicole Soranzo has been elected to the Academy of Medical Sciences
Professor Nicole Soranzo has been elected to the Academy of Medical Sciences. The award recognises her research into how the human genome influences the risk of common diseases, in particular disorders of immunity and inflammation. Image credit: Wellcome Sanger Institute, Genome Research Limited

Professor Soranzo leads the Human Complex Traits research group, which studies how the human genome influences the risk of common diseases, in particular disorders of immunity and inflammation. Her research team, based at the Sanger Institute and the University of Cambridge School of Clinical Medicine, applies cutting-edge genomic analysis, epigenetic profiling and in-depth clinical measurements to population-based cohorts, to unpick the genetic and epigenetic causes of many common human diseases.

As an example of this work, analysing data from the BLUEPRINT and UK Biobank projects, Nicole's group has generated the most comprehensive to date map of genomic locations associated with the physical and molecular properties of blood cells. She further showed how these genetic differences are linked to increased risk of many common diseases, for instance cardiovascular diseases and autoimmune diseases such as asthma and rheumatoid arthritis. Finally, using high-resolution molecular analysis, she has shown how these data genetic data can informs the search of genes that can be targeted to treat the disease.

“I am honoured to be joining the Fellowship of the Academy of Medical Sciences. This award recognises the essential contribution of my talented research team, of the Sanger Institute research teams more broadly, as well as many worldwide colleagues who have empowered our genomic research by recruiting detailed information on the clinical and biological characteristics of our study populations. I am particularly grateful to the hundreds of thousands of volunteers who have selflessly gifted their time to enrich biomedical research. I will be delighted to continue to be able to contribute our results to open-access databases to benefit global research efforts."

Professor Nicole Soranzo, Group Leader at the Wellcome Sanger Institute and the University of Cambridge School of Clinical Medicine

Dr David Adams has been elected to Fellowship of the Academy of Medical Sciences
Dr David Adams has been elected to Fellowship of the Academy of Medical Sciences. The award recognises his research into how cancers develop by using DNA sequencing of patient samples and genetic screens in human cells and mice. Image credit: Wellcome Sanger Institute, Genome Research Limited

Dr Adams studies how cancers develop by studying the effect that damage to specific genes has on driving cells to become cancerous. To achieve this, David's Experimental Cancer Genetics research team uses DNA sequencing of patient samples and genetic screens in human cells and mice to identify cancer genes and to understand how they interact.

The group have a particular focus on how melanoma, a type of skin cancer, evolves and has been analysing the genomes of families with a high incidence of this malignancy. The group also performs large-scale functional studies in cultured cells and in mice to understand how factors such as DNA mutations and the immune system influence tumour growth.

Using these approaches David’s team has identified new genes that regulate the spread of cancer. Targeting these proteins that the genes produce with drugs could offer new ways to help prevent metastases from forming.

"It is an honour to be recognised by the Academy of Medical Sciences. Untangling how cancer develops in cells and evolves requires an enormous collective effort. I am grateful for the dedication and creativity of my team and my colleagues as we work together to uncover cancer's secrets. This award is as much theirs as it is mine."

Dr David Adams, Group Leader at the Wellcome Sanger Institute

Nicole and David will be formally admitted into the Academy at a ceremony on 27 June 2018.

Notes to Editors

The Academy of Medical Sciences is the independent body in the UK representing the diversity of medical science. The Academy’s elected Fellows are the UK’s leading medical scientists from hospitals, academia, industry and the public service. Its mission is to advance biomedical and health research and its translation into benefits for society. We are working to secure a future in which:

  • UK and global health is improved by the best research.
  • The UK leads the world in biomedical and health research, and is renowned for the quality of its research outputs, talent and collaborations.
  • Independent, high quality medical science advice informs the decisions that affect society.
  • More people have a say in the future of health and research.

The work of the Academy focuses on four key objectives, promoting excellence, developing talented researchers, influencing research and policy and engaging patients, the public and professionals.

https://acmedsci.ac.uk

Selected Websites

Recent News

Deadly malaria’s evolution revealed

Study shows Plasmodium falciparum emerged earlier than thought and gives clues to how deadly parasites arise

Gonorrhoea surveillance study maps antibiotic resistance across Europe

Genomic approach could help doctors monitor emerging resistance and prescribe most effective antibiotics in the future

Sanger’s Head of Cancer, Ageing and Somatic Mutation Programme honoured by EMBO

Dr Peter Campbell becomes an elected member of the European Molecular Biology Organization